Applications of (S)-(-)-2-Methyl-1-Butanol in Industrial Manufacturing

(S)-(-)-2-Methyl-1-Butanol plays a specialized role in select industrial production processes, where its unique chiral properties contribute to formulation specificity, reaction efficiency, and end-product purity. As an experienced manufacturer, we supply this raw material to downstream customers across key sectors with critical quality demands. The following application scenarios detail real-world uses, with each segment highlighting industry standards, targeted formulation use, integration into production, and final product categories.

1. Chiral Intermediate in Pharmaceutical API Synthesis

Pharmaceutical producers use (S)-enantiomeric 2-Methyl-1-Butanol as a chiral building block, where its optical purity directly affects enantioselective synthesis of APIs such as statins, antiretrovirals, and certain antivirals. During asymmetric reduction and alkylation steps, this alcohol participates as a key intermediate to enable the required stereochemistry in the target molecule. Quality control of the raw material's enantiopurity is critical throughout batch synthesis to meet tight pharmacopoeia monograph specifications and minimize risk of harmful isomer formation.

Industry compliance standards

• ICH Q7 - Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP) recognition for chiral intermediates
• 21 CFR Part 211 cGMP
• ISO 9001:2015-certified QC systems for traceability

Typical usage ratio

• Reaction charge levels range from 0.5 to 2.5 molar equivalents, adjusted based on stoichiometry of the target chiral API and efficiency of the catalyst system

Downstream process integration

• Introduced during early-stage asymmetric synthesis steps (e.g., Grignard reactions, catalytic hydrogenations), followed by purification and isolation

Final product types

• Finished chiral pharmaceutical APIs for cardiovascular, antiviral, and anti-inflammatory drug formulations
• Registered pharmaceutical intermediates supplied to drug development companies

2. Aroma Ingredient in Flavors and Fragrances Manufacturing

Flavor and fragrance manufacturers employ (S)-(-)-2-Methyl-1-Butanol due to its distinctively mild fruity and green sensory note, which provides authentic complexity in compound mixes for food, beverage, and personal care products. Its chiral purity ensures consistent aromatic performance, particularly in enantiomerically sensitive formulations where the scent profile must remain stable and legislatively compliant.

Industry compliance standards

• IFRA Standards (International Fragrance Association)
• FDA 21 CFR 172.515 (Flavoring Agents and Related Substances)
• EU Regulation No 1334/2008 (Flavourings and certain food ingredients)
• FEMA GRAS certification for use in flavorings

Typical usage ratio

• Common dosage between 3 ppm to 15 ppm in compound flavors, or up to 0.1% w/w in fragrance composites, varying by end-use intensity and blend composition

Downstream process integration

• Blended post-distillation into flavor or fragrance bases; incorporated during compounding before emulsification or encapsulation steps

Final product types

• Beverage flavorings (e.g., spirits, fruit drinks)
• Fine fragrance concentrates for cosmetics
• Seasoning blends for savory and sweet foods
• Personal care fragrance bases (e.g., shampoos, lotions)

3. Enantioselective Synthesis of Agrochemical Actives

Producers of specialty agrochemicals integrate this chiral alcohol into enantioselective synthesis pathways for active ingredients. Here, the alcohol serves as a starter unit or resolving agent, imparting desired configuration to molecules in fungicides, insecticides, and herbicides. Downstream manufacturers emphasize trace enantiomeric purity to maintain regulated activity and environmental profile in end products.

Industry compliance standards

• FAO/WHO Guidance on Pesticide Specifications
• REACH Regulation (EC) No 1907/2006 for substance registration
• ISO 17025-accredited analytical validation for enantiomeric excess
• OECD Principles of Good Laboratory Practice (GLP)

Typical usage ratio

• Introduced at 1.0 to 2.0 mole equivalents relative to the target synthetic intermediate, adjusted by process efficiency

Downstream process integration

• Used during the synthesis or resolution of chiral agrochemical intermediates prior to final functional group modification

Final product types

• Enantio-enriched fungicide actives
• Chiral insecticide precursors
• Specialized herbicide molecules for regulated markets

4. Stereospecific Solvent or Reaction Modifier in Fine Chemical Synthesis

In the manufacture of optically active fine chemicals, specialty synthesis routes incorporate (S)-(-)-2-Methyl-1-Butanol as a chiral reaction medium or as a resolving agent for other enantiomeric compounds. This approach promotes selective crystallization or facilitates targeted stereoselective transformations in laboratories and production plants making high-value intermediates.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• SOCMA ChemStewards® for process safety and product stewardship in fine chemicals
• Environmental Protection Agency (EPA) requirements for solvent waste handling
• GMP guidelines for specialty chemical manufacturing

Typical usage ratio

• Utilized at levels from 5% to 20% v/v of total reaction volume, depending on solubility profiles and chiral selectivity targets

Downstream process integration

• Added directly as solvent or chiral modifier during crystallization or chiral resolution steps within multistep syntheses

Final product types

• Optically pure intermediates for novel material development
• High-purity building blocks for research-scale and pilot manufacturing
• Custom chiral reagents for specialty industrial use